Chrysalis Biotherapeutics
Galveston, US
Biotech
Founders & leadership
LS
Lauri SowerExecutive Officer
DC
Darrell CarneyExecutive Officer, Director
TS
Timothy SchmidtDirector
JR
James RyabyDirector
MR
Marie RobbDirector
JS
Jeffery SheldonDirector
Reported raises · per SEC filings
Form D private placements▶$515KraisedMar 2024 · 12 investors · PharmaceuticalsRule 506(b)
▶$515KraisedMar 2024 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lauri SowerExecutive Officer
- Darrell CarneyExecutive Officer, Director
- Timothy SchmidtDirector
- James RyabyDirector
- Marie RobbDirector
- Jeffery SheldonDirector
- Offering amount
- $3M
- Amount sold
- $515K
- Minimum investment
- $10K
- Proceeds to insiders
- $139K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.